YUHSpace: 1. Journal Papers
menu
About
Yonsei University Medical Library
검색
All
Title
Author
Keyword / MeSH
Year
Journal Title
Contains
Equals
YUHASpace Repository
YUHSpace
About YUHSpace
Guildeline
BROWSE
Colleges & Departments
Yonsei Authors
Medical Student Research Advisor
Titles
Journal Titles
Publication Year
YUHS Publication
(연세의료원 간행물)
YUHSpace
1. College of Medicine (의과대학)
Dept. of Internal Medicine (내과학교실)
1. Journal Papers
search for
or browse
Issue Date
Author
Title
Other Title
Identifier
Subscribe to this collection to receive daily e-mail notification of new additions
This table browses all dspace content
Issue Date
Title
Journal Title
2025
Proportion of histologic component predicts lymph node metastasis risk in undifferentiated-type mucosal and submucosal gastric cancers
VIRCHOWS ARCHIV
2025
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
BMC CANCER
2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial
CIRCULATION
2025
Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study
JOURNAL FOR IMMUNOTHERAPY OF CANCER
2025
A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19
NATURE COMMUNICATIONS
2025
Utility of Non-HLA Autoantibodies in Predicting Graft Survival After Heart Transplantation
TRANSPLANTATION
2025
Machine learning prediction of in-hospital mortality and external validation in patients with cardiogenic shock: the RESCUE score
REVISTA ESPANOLA DE CARDIOLOGIA
2025
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
JOURNAL OF HEPATOLOGY
2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study
ANNALS OF ONCOLOGY
2025
Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study
EUROPEAN JOURNAL OF CANCER
2025
Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab
OSTEOPOROSIS INTERNATIONAL
2025
Evolving roles of MET as a therapeutic target in NSCLC and beyond
NATURE REVIEWS CLINICAL ONCOLOGY
2025
Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy
JOURNAL OF CLINICAL MEDICINE
2025
An Artificial Intelligence-Enabled Electrocardiogram to Evaluate Patients With Dyspnea in the Emergency Department
MAYO CLINIC PROCEEDINGS-INNOVATIONS QUALITY & OUTCOMES
2025
BP and Kidney Disease Progression in Advanced CKD Findings from the Chronic Renal Insufficiency Cohort and KoreaN Cohort Study for Outcome in Patients with CKD Studies
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
2025
Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006-2022)
OSTEOPOROSIS INTERNATIONAL
2025
FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma
CANCER TREATMENT REVIEWS
2025
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort
CANCER
2025
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
JOURNAL OF CLINICAL ONCOLOGY
2025
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
LANCET ONCOLOGY
1
40
41
42
43
44
45
46
47
48
49
50
51
791
Recent Submissions
Browse
Communities & Collections
Titles
Yonsei Authors
Journal Titles
By date
Links
About
Yonsei University Medical Library